The TWIML AI Podcast (formerly This Week in Machine Learning & Artificial Intelligence)
Machine Learning: A New Approach to Drug Discovery with Daphne Koller - #332
26 Dec 2019
Today we’re joined by Daphne Koller, co-Founder and former co-CEO of Coursera and Founder and CEO of Insitro. In our conversation, discuss the current landscape of pharmaceutical drugs and drug discovery, including the current pricing of drugs, and an overview of Insitro’s goal of using ML as a “compass” in drug discovery. We also explore how Insitro functions as a company, their focus on the biology of drug discovery and the landscape of ML techniques being used, Daphne’s thoughts on AutoML, and
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
SpaceX Said to Pursue 2026 IPO
10 Dec 2025
Bloomberg Tech
Don’t Call It a Comeback
10 Dec 2025
Motley Fool Money
Japan Claims AGI, Pentagon Adopts Gemini, and MIT Designs New Medicines
10 Dec 2025
The Daily AI Show
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare
What it will take for AI to scale (energy, compute, talent)
10 Dec 2025
Azeem Azhar's Exponential View
Reducing Burnout and Boosting Revenue in ASCs
10 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast